Edition:
United Kingdom

Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

38.63EUR
11 Dec 2017
Change (% chg)

€-0.05 (-0.13%)
Prev Close
€38.68
Open
€38.68
Day's High
€38.80
Day's Low
€38.50
Volume
204,770
Avg. Vol
350,819
52-wk High
€40.80
52-wk Low
€25.53

Chart for

About

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central... (more)

Overall

Beta: 0.54
Market Cap(Mil.): €8,275.08
Shares Outstanding(Mil.): 209.13
Dividend: 0.35
Yield (%): 1.77

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Recordati Q3 net profit up at EUR ‍​72.8 mln, confirms FY targets

* Q3 NET PROFIT EUR ‍​72.8 MILLION VERSUS EUR 59.6 MILLION YEAR AGO

26 Oct 2017

BRIEF-Recordati H1 net profit up at EUR 147.0 mln, raises FY 2017 targets

July 27 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA:

27 Jul 2017

BRIEF-Recordati: European Commission approves Reagila as schizophrenia treatment

* EUROPEAN COMMISSION APPROVES REAGILA (CARIPRAZINE) FOR TREATMENT OF SCHIZOPHRENIA Source text: http://bit.ly/2teBSwQ Further company coverage: (Gdynia Newsroom)

19 Jul 2017

BRIEF-Recordati signs exclusive license agreement with MimeTech

June 16 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA:

16 Jun 2017

Earnings vs. Estimates